HMGB1 and acute respiratory distress syndrome: In 2018, Zhang et al. [48] proposed a new molecular mechanism of ketamine (a known anesthetic compound; Figure 4) to treat ALI and proposed that it blocks the HMGB1/RAGE signaling pathway.